Related references
Note: Only part of the references are listed.The LDL Receptor
Joseph L. Goldstein et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Poly(C)-binding proteins as transcriptional regulators of gene expression
Hack Sun Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Novel Nonstatin Strategies to Lower Low-Density Lipoprotein Cholesterol
Michael H. Davidson
CURRENT ATHEROSCLEROSIS REPORTS (2009)
PCSK9 as a therapeutic target of dyslipidemia
Nabil G. Seidah
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Hepatocyte Nuclear Factor 1α Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
Hai Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
PCSK9: a convertase that coordinates LDL catabolism
Jay D. Horton et al.
JOURNAL OF LIPID RESEARCH (2009)
Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements
Hai Li et al.
JOURNAL OF LIPID RESEARCH (2009)
Landscape of the hnRNP K protein-protein interactome
M Mikula et al.
PROTEOMICS (2006)
Protocol for the fast chromatin immunoprecipitation (ChIP) method
Joel D. Nelson et al.
NATURE PROTOCOLS (2006)
hnRNP K: An HDM2 target and transcriptional coactivator of p53 in response to DNA damage
A Moumen et al.
CELL (2005)
hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation
M Lynch et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Heterogeneous nuclear ribonucleoprotein K represses transcription from a cytosine/thymidine-rich element in the osteocalcin promoter
JP Stains et al.
BIOCHEMICAL JOURNAL (2005)
Characterization of hnRNP K protein-RNA interactions
K Klimek-Tomczak et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins
WJ Kong et al.
NATURE MEDICINE (2004)
Cooperative binding of the hnRNP K three KH domains to mRNA targets
A Paziewska et al.
FEBS LETTERS (2004)
HnRNP K: One protein multiple processes
K Bomsztyk et al.
BIOESSAYS (2004)
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
DJ Rader et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Posttranscriptional control of renin synthesis -: Identification of proteins interacting with renin mRNA 3′-untranslated region
A Skalweit et al.
CIRCULATION RESEARCH (2003)
Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K:: implications in the regulation of SRC1A transcription
SA Ritchie et al.
NUCLEIC ACIDS RESEARCH (2003)
hnRNP-K and Purα act together to repress the transcriptional activity of the CD43 gene promoter
N Da Silva et al.
BLOOD (2002)
Identification of Egr1 as the oncostatin M-induced transcription activator that binds to sterol-independent regulatory element of human LDL receptor promoter
F Zhang et al.
JOURNAL OF LIPID RESEARCH (2002)
Molecular basis of sequence-specific single-stranded DNA recognition by KH domains: solution structure of a complex between hnRNP KKH3 and single-stranded DNA
DT Braddock et al.
EMBO JOURNAL (2002)
Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative Exon 6A from Chicken β-tropomyosin Pre-mRNA
A Expert-Bezançon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Heterogeneous nuclear ribonucleoprotein K protein associates with multiple mitochondrial transcripts within the organelle
J Ostrowski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The poly(C)-binding proteins: A multiplicity of functions and a search for mechanisms
AV Makeyev et al.
RNA (2002)
Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter
JW Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
